Image 1
Chemical structure diagram of ethinyl estradiol, showing the molecular formula C20H26O2 and molecular weight 298.42.*
Aranelle Kit
Product Images NDC 0555-9066
6 FDA label images from Teva Pharmaceuticals Usa, Inc. · Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Aranelle (NDC 0555-9066). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Teva Pharmaceuticals Usa, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Image 2
Chemical structure diagram of ethinyl estradiol, showing molecular formula C20H24O2 and molecular weight 296.40.*
Image 3
Bar graph showing circulatory disease mortality rates per 100,000 woman years by age group (15-24, 25-34, 35-44, 45+) for ever-users and controls of oral contraceptives, separated by smoking status (smokers and nonsmokers). The graph depicts mortality rate increasing with age, particularly among smokers who are ever-users.*
Image 4
A forest plot showing effect estimates (odds ratios or relative risks) with 95% confidence intervals from multiple studies on contraceptive use. The studies include NICHD, French E3N cohort, Shanghai Women's Health, Nurses’ Health Study II, Oxford Family Planning, and Danish Sex Hormone Register, illustrating varying effect sizes around 1.0 on the x-axis, indicating a range of associations between contraceptive use and the outcome measured.*
Image 5
Aranelle kit containing 28-day oral tablets of norethindrone and ethinyl estradiol. The rectangular tablet pack includes four rows of circular tablets with different colors: light yellow, white, white and light yellow, and peach, organized by week and day of the week. The label includes storage instructions and the product NDC 0555-9066, distributed by Teva Pharmaceuticals USA, Inc.*
Image 6
Packaging label for Aranelle (norethindrone and ethinyl estradiol tablets USP) triphasic regimen kit. The label shows a 28-day regimen with 3 tablet dispensers, each containing 28 tablets, manufactured by Teva Pharmaceuticals USA, Inc. The label includes regulatory and usage information with the product NDC 0555-9066-67.*
* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.
